⌘K

Home/Filings/4/0001209191-23-044408

4//SEC Filing

BARTLETT ROBERT F 4

Accession 0001209191-23-044408

CIK 0001006028other

View on SEC.gov Company Profile

Filed

Aug 2, 8:00 PM ET

Accepted

Aug 3, 4:13 PM ET

Size

5.6 KB

Accession

0001209191-23-044408

Insider Transaction Report

Form 4

Period: 2023-08-01

PURE BIOSCIENCE, INC.PURE

BARTLETT ROBERT F

DirectorCEO

Transactions

Award
Stock Option (Right to Buy)
2023-08-01+150,000→ 150,000 total
Exercise: $0.12Exp: 2033-08-01→ Common Stock (150,000 underlying)

Footnotes (1)

[F1]The option shares shall vest and become exercisable in four equal installments on November 1, 2023, February 1, 2024, May 1, 2024, and August 1, 2024.

Documents

1 file

4
doc4.xmlPrimary
FORM 4 SUBMISSION

Issuer

PURE BIOSCIENCE, INC.

CIK 0001006028

Entity typeother

Related Parties

1

filerCIK 0001240229

Filing Metadata

Form type: 4
Filed: Aug 2, 8:00 PM ET
Accepted: Aug 3, 4:13 PM ET
Size: 5.6 KB

View on SEC.gov